help button home button Am J Pathol Epitomics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davis, R. L.
Right arrow Articles by Lawrence, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, R. L.
Right arrow Articles by Lawrence, D. A.
(American Journal of Pathology. 1999;155:1901-1913.)
© 1999 American Society for Investigative Pathology

Regular Articles

Familial Encephalopathy with Neuroserpin Inclusion Bodies

Richard L. Davis*, Peter D. Holohan{dagger}, Antony E. Shrimpton*, Arthur H. Tatum*, John Daucher*, George H. Collins*, Robert Todd{ddagger}, Charles Bradshaw{ddagger}, Paul Kent{ddagger}, David Feiglin§, Arthur Rosenbaum, Mark S. Yerby||, Cheng-Mei Shaw**, Felicitas Lacbawan{dagger}{dagger} and Daniel A. Lawrence{ddagger}{ddagger}

From the Departments of Pathology,*
Pharmacology,{dagger}
Neurology,{ddagger}
Nuclear Medicine,§
and Radiology,
State University of New York Health Science Center, Syracuse, New York; the Departments of Neurology, Public Health, and Obstetrics and Gynecology,||
Oregon Health Sciences University, Portland, Oregon; the Department of Pathology,**
University of Washington School of Medicine, Seattle, Washington; the National Human Genome Research Institute,{dagger}{dagger}
National Institutes of Health, Bethesda, Maryland; and the American Red Cross Holland Laboratories,{ddagger}{ddagger}
Rockville, Maryland

We report on a new familial neurodegenerative disease with associated dementia that has presented clinically in the fifth decade, in both genders, and in each of several generations of a large family from New York State—a pattern of inheritance consistent with an autosomal dominant mode of transmission. A key pathological finding is the presence of neuronal inclusion bodies distributed throughout the gray matter of the cerebral cortex and in certain subcortical nuclei. These inclusions are distinct from any described previously and henceforth are identified as Collins bodies. The Collins bodies can be isolated by simple biochemical procedures and have a surprisingly simple composition; neuroserpin (a serine protease inhibitor) is their predominant component. An affinity-purified antibody against neuroserpin specifically labels the Collins bodies, confirming their chemical composition. Therefore, we propose a new disease entity—familial encephalopathy with neuroserpin inclusion bodies (FENIB). The conclusion that FENIB is a previously unrecognized neurodegenerative disease is supported by finding Collins bodies in a small kindred from Oregon with familial dementia who are unrelated to the New York family. The autosomal dominant inheritance strongly suggests that FENIB is caused by mutations in the neuroserpin gene, resulting in intracellular accumulation of the mutant protein.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. J. Davies, E. Miranda, B. D. Roussel, R. J. Kaufman, S. J. Marciniak, and D. A. Lomas
Neuroserpin Polymers Activate NF-{kappa}B by a Calcium Signaling Pathway That Is Independent of the Unfolded Protein Response
J. Biol. Chem., July 3, 2009; 284(27): 18202 - 18209.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Takasawa, I. Kato, K. Takasawa, Y. Ishii, T. Yoshida, M. H. Shehata, H. Kawaguchi, O. M. M. Mohafez, M. Sasahara, and K. Hiraga
Mutation-, Aging-, and Gene Dosage-dependent Accumulation of Neuroserpin (G392E) in Endoplasmic Reticula and Lysosomes of Neurons in Transgenic Mice
J. Biol. Chem., December 19, 2008; 283(51): 35606 - 35613.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
E. Miranda, I. MacLeod, M. J. Davies, J. Perez, K. Romisch, D. C. Crowther, and D. A. Lomas
The intracellular accumulation of polymeric neuroserpin explains the severity of the dementia FENIB
Hum. Mol. Genet., June 1, 2008; 17(11): 1527 - 1539.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
H. M. Nielsen, L. Minthon, E. Londos, K. Blennow, E. Miranda, J. Perez, D. C. Crowther, D. A. Lomas, and S. M. Janciauskiene
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies
Neurology, October 16, 2007; 69(16): 1569 - 1579.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
E. E. Benarroch
Tissue plasminogen activator: Beyond thrombolysis
Neurology, August 21, 2007; 69(8): 799 - 802.
[Full Text] [PDF]

Home page
 NeurologyHome page
I. Gourfinkel-An, C. Duyckaerts, A. Camuzat, C. Meyrignac, P. Sonderegger, M. Baulac, and A. Brice
Clinical and neuropathologic study of a French family with a mutation in the neuroserpin gene
Neurology, July 3, 2007; 69(1): 79 - 83.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. Galliciotti, M. Glatzel, J. Kinter, S. V. Kozlov, P. Cinelli, T. Rulicke, and P. Sonderegger
Accumulation of Mutant Neuroserpin Precedes Development of Clinical Symptoms in Familial Encephalopathy with Neuroserpin Inclusion Bodies
Am. J. Pathol., April 1, 2007; 170(4): 1305 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
M. Yepes and D. A. Lawrence
New Functions for an Old Enzyme: Nonhemostatic Roles for Tissue-Type Plasminogen Activator in the Central Nervous System
Experimental Biology and Medicine, December 1, 2004; 229(11): 1097 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Miranda, K. Romisch, and D. A. Lomas
Mutants of Neuroserpin That Cause Dementia Accumulate as Polymers within the Endoplasmic Reticulum
J. Biol. Chem., July 2, 2004; 279(27): 28283 - 28291.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Makarova, I. Mikhailenko, T. H. Bugge, K. List, D. A. Lawrence, and D. K. Strickland
The Low Density Lipoprotein Receptor-related Protein Modulates Protease Activity in the Brain by Mediating the Cellular Internalization of Both Neuroserpin and Neuroserpin-Tissue-type Plasminogen Activator Complexes
J. Biol. Chem., December 12, 2003; 278(50): 50250 - 50258.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
A. Williams
Defining neurodegenerative diseases
BMJ, June 22, 2002; 324(7352): 1465 - 1466.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Belorgey, D. C. Crowther, R. Mahadeva, and D. A. Lomas
Mutant Neuroserpin (S49P) That Causes Familial Encephalopathy with Neuroserpin Inclusion Bodies Is a Poor Proteinase Inhibitor and Readily Forms Polymers in Vitro
J. Biol. Chem., May 3, 2002; 277(19): 17367 - 17373.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. W. Carrell and D. A. Lomas
Alpha1-Antitrypsin Deficiency -- A Model for Conformational Diseases
N. Engl. J. Med., January 3, 2002; 346(1): 45 - 53.
[Full Text] [PDF]

Home page
 Arch NeurolHome page
C. B. Bradshaw, R. L. Davis, A. E. Shrimpton, P. D. Holohan, C. B. Rea, D. Fieglin, P. Kent, and G. H. Collins
Cognitive Deficits Associated With a Recently Reported Familial Neurodegenerative Disease: Familial Encephalopathy With Neuroserpin Inclusion Bodies
Arch Neurol, September 1, 2001; 58(9): 1429 - 1434.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Yazaki, J. J. Liepnieks, J. R. Murrell, M. Takao, B. Guenther, P. Piccardo, M. R. Farlow, B. Ghetti, and M. D. Benson
Biochemical Characterization of a Neuroserpin Variant Associated with Hereditary Dementia
Am. J. Pathol., January 1, 2001; 158(1): 227 - 233.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.